Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Alexander Borck, Aurachtal DE

Alexander Borck, Aurachtal DE

Patent application numberDescriptionPublished
20080215140STENTS COATED WITH BIOMOLECULES AND PROCESS FOR THEIR PRODUCTION - A stent comprising a basic stent body, at least one anchor group on the surface of the basic stent body, and at least one biomolecule which is bound to the at least one anchor group, the anchor group being the same or different and selected from the group of compounds with the general formula (I)09-04-2008
20080234790Implantable Stimulation Electrode with a Coating for Increasing Tissue Compatibility - An implantable stimulation electrode for use with an implantable tissue stimulator, especially a pacemaker, a defibrillator, a bone stimulator or a neurostimulator includes a metal base body, optionally one or more intermediate layers disposed on the base body and a coating covering the base body and, optionally, intermediate layers in order to increase tissue compatibility. The coating should prevent tissue irritations after implantation and more particularly increase the stimulus threshold associated therewith, have very high biocompatibility and also has an anti-inflammatory effect. An increase in tissue compatibility is achieved by virtue of the fact that the coating has a polysaccharide layer made of hyaluronic acid and/or hyaluronic acid derivatives.09-25-2008
20090076596STENT HAVING A COATING - A stent having a coating comprising either L-3,4-dihydroxyphenylalanine (L-DOPA) or a derivative of L-3,4-dihydroxyphenylalanine (L-DOPA), the foregoing obtained by either ionic or covalent bonding of a pharmaceutical active ingredient to either the amino or the acid function of L-3,4-dihydroxyphenylalanine (L-DOPA).03-19-2009
20090112307STENT HAVING A BASE BODY OF A BIOINERT METALLIC IMPLANT MATERIAL - A stent having a base body of a bioinert metallic implant material wherein the base body is covered with an SiC coating. An external surface of the base body has a plurality of cavities which are filled with an antiproliferative active ingredient, A luminal surface of the base body has a coating which contains or comprises attractors for endothelial cells.04-30-2009
20090192594IMPLANT HAVING A BASE BODY OF A BIOCORRODIBLE ALLOY AND A CORROSION-INHIBITING COATING - An implant having a base body consisting entirely or in part of a biocorrodible metallic material wherein at least the parts of the base body made of the biocorrodible metallic material are covered with a corrosion-inhibiting coating. The coating comprises a primer layer of a first biodegradable polymer material comprising a poly(D,L-lactide) (PDLLA) with a degree of polymerization in the range of 5 to 20 and a protective layer of a second biodegradable polymer material comprising a diblock copolymer (PEG/PLGA) of polyethylene glycol (PEG) and poly(D,L-lactide-co-glycolide) (PLGA) applied to the primer layer.07-30-2009
20090270977STENT FIXATION SYSTEM - A stent fixation system 10-29-2009
20090274737IMPLANT COMPRISING A SURFACE OF REDUCED THROMBOGENICITY - An implant for a human or animal body, comprising a surface having reduced thrombogenic properties, whose surface has a wetting angle of Θ, where Θ≦80°. Also disclosed is a method for producing an implant and the use an implant to reduce the dose or concentration in administration of a concomitant systemic medication with one or more anticoagulant active ingredients before, during or after implantation of the implant in a human or animal body.11-05-2009
20090311304DRUG-LOADED IMPLANT - The invention relates to a drug-loaded implant having a carrier body (12-17-2009
20100015201IMPLANT WITH COATING - The present invention concerns an implant with a molecularly imprinted polymer coating, a process for its synthesis, a molecularly imprinted polymer, as well as a process for its synthesis and its use as well as a process for the treatment or prophylaxis of certain disease conditions by implantation of an implant in accordance with the invention according to the respective independent claims.01-21-2010
20100023112BIOCORRODIBLE IMPLANT WITH A COATING COMPRISING A HYDROGEL - The invention relates to an implant having a base body consisting completely or partially of a biocorrodible metallic material, the material being such that it decomposes in an aqueous environment to yield an alkaline product and the base body has a coating comprising or containing a hydrogel, characterized in that the hydrogel has a reduced swelling capacity at an elevated pH.01-28-2010
20100023116BIOCORRODIBLE IMPLANT WITH A COATING CONTAINING A DRUG ELUTING POLYMER MATRIX - The invention relates to an implant having a base body, consisting completely or partially of a biocorrodible metallic material, such that it decomposes in an aqueous environment to form an alkaline product, and the base body has a coating or a cavity filling, comprising a polymer matrix and at least one drug embedded in the polymer matrix, characterized in that at least one polymer of the matrix and the at least one drug are coordinated so that the drug elution rate from the matrix is increased with an increase in pH.01-28-2010
20100119581Medical Products That Release Pharmaceutically Active Substances - The present invention concerns medical products that release pharmaceutically active substances, the efficiency of which is increased as the result of a combination with an inhibitor of the transport protein P-glycoprotein.05-13-2010
20100331966BIOCORRODIBLE IMPLANT HAVING AN ACTIVE COATING - One embodiment of the invention relates to an implant having a basic body composed of a biocorrodible material and having an active coating or filling of a cavity, consisting of or containing the components 12-30-2010
20110034990BIOCORRODIBLE IMPLANT WITH ACTIVE COATING - One embodiment of the invention concerns an implant with a basic body of biocorrodible, metallic implant material with an active coating and/or cavity filling.02-10-2011
20110034996MEDICAL IMPLANT CONTAINING AN ANTIOXIDATIVE SUBSTANCE - One embodiment of the invention concerns a medical implant with the basic body having an antioxidative substance.02-10-2011
20110150964APTAMER-COATED IMPLANT, PROCESS OF PRODUCTION, AND USES - One embodiment of the present invention is an implant with an aptamer coating, wherein the aptamer has an activating effect on the α06-23-2011
20110152766IMPLANT WITH COATING - One embodiment of the invention relates to an implant with a coating containing at least one active pharmaceutical substance. The inventive implant is characterized in that the coating is covered by a protective layer comprising or containing one or more materials from the group including shellac, vinylpyrrolidone-vinyl acetate copolymer, vinyl acetate-crotonic acid copolymer, vinyl acetate-vinyl propionate-crotonic acid terpolymer, methylvinyl ether-maleic anhydride copolymer, vinylpyrrolidone-dimethylaminoethyl acrylate copolymer, polyvinylpyrrolidone, polyvinyl acetate, polycrotonic acid, polyvinyl propionate, polymethylvinyl ether, polymaleic anhydride and polydimethylaminoethyl acrylate.06-23-2011

Patent applications by Alexander Borck, Aurachtal DE